Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03563313 · ClinicalTrials.gov registry record · NA
The International Diabetes Closed Loop (iDCL) Trial: Clinical Acceptance of the Artificial Pancreas
A NA study, sponsored by University of Virginia.
- Completed
- Registry status
- NA
- Development phase
- 168
- Enrollment target
NCT03563313: Completed NA study, sponsored by University of Virginia.
NCT03563313 is a NA study that has completed, run by University of Virginia. The registered enrollment target is 168 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03563313, a NA study, has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- NA
- Development phase
- 168 participants
- Enrollment target
Study Summary
The objective of the study is to assess efficacy and safety of a closed loop system (t:slim X2 with Control-IQ Technology) in a large randomized controlled trial.
Primary Outcome
The primary outcome is time in target range 70-180 mg/dL measured by CGM in CLC group vs. SAP group.
Interventions
- DEVICE t:slim X2 with Control-IQ Technology & Dexcom G6 CGM
- DEVICE Sensor-augmented pump (SAP)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 168 participants |
| Start Date | 2018-06-28 |
| Est. Completion | 2019-04-08 |
| Phase | NA |
What the finished NCT03563313 record still lists
NCT03563313 is an interventional study that assigns participants to a tested intervention. The registered 168 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower).
The record links to 0 conditions, and to 2 interventions - of which t:slim X2 with Control-IQ Technology & Dexcom G6 CGM is the first listed.
NCT03563313 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03563313 about?
NCT03563313 is a clinical study titled "The International Diabetes Closed Loop (iDCL) Trial: Clinical Acceptance of the Artificial Pancreas". The objective of the study is to assess efficacy and safety of a closed loop system (t:slim X2 with Control-IQ Technology) in a large randomized controlled trial.
What is the current status of trial NCT03563313?
This trial is currently completed. It is a NA study. The enrollment target is 168 participants. The study started on 2018-06-28. Estimated completion is 2019-04-08.
What interventions are being tested in trial NCT03563313?
The interventions under investigation include: t:slim X2 with Control-IQ Technology & Dexcom G6 CGM (DEVICE), Sensor-augmented pump (SAP) (DEVICE).
Who is sponsoring clinical trial NCT03563313?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03563313's enrollment target sits among peer trials
168 619th of 2000 higher than 1,379 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02118922 · 168 participants
A Study to Test the Diagnostic Potential of Brillouin Microscopy for Corneal Ectasia
- NCT03536897 · 168 participants
IORT Following Breast Conserving Surgery for Early Stage Breast Cancer Registry
- NCT04078230 · 168 participants · NA
Regional or Extend LymphAdenectomy During Resection of Intrahepatic Cholangiocarcinoma
- NCT04159168 · 168 participants · NA
Facial Affect Sensitivity Training for Young Children With Callous-unemotional Traits
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI